<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>caspofungin</title><link>http://www.unboundmedicine.com/medline/ebm/research/caspofungin</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Wild-type MIC Distributions and Epidemiological Cutoff Values (ECVs) for the Echinocandins and Candida spp.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19923478/full_citation/Wild_type_MIC_Distributions_and_Epidemiological_Cutoff_Values__ECVs__for_the_Echinocandins_and_Candida_spp_</link><description>Pfaller MA, Boyken L, Hollis RJ, et al. <br/><span class="title">Wild-type MIC Distributions and Epidemiological Cutoff Values (ECVs) for the Echinocandins and Candida spp. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of clinical microbiology">J Clin Microbiol 2009 Nov 18.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19923478/abstract/Wild_type_MIC_Distributions_and_Epidemiological_Cutoff_Values__ECVs__for_the_Echinocandins_and_Candida_spp_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19923478/full_citation/Wild_type_MIC_Distributions_and_Epidemiological_Cutoff_Values__ECVs__for_the_Echinocandins_and_Candida_spp_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19923478/Wild_type_MIC_Distributions_and_Epidemiological_Cutoff_Values__ECVs__for_the_Echinocandins_and_Candida_spp_">Find Related Articles</a> </description></item><item><title>Nosocomial candidemia at a general hospital: prognosis factors and impact of early empiric treatment on outcome (2002-2005).</title><link>http://www.unboundmedicine.com/medline/ebm/record/19913258/full_citation/Nosocomial_candidemia_at_a_general_hospital:_prognosis_factors_and_impact_of_early_empiric_treatment_on_outcome__2002_2005__</link><description>Gómez J, García-Vázquez E, Espinosa C, et al. <br/><span class="title">Nosocomial candidemia at a general hospital: prognosis factors and impact of early empiric treatment on outcome (2002-2005). [JOURNAL ARTICLE]</span><br/><span class="source" title="Medicina clinica">Med Clin (Barc) 2009 Nov 11.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19913258/abstract/Nosocomial_candidemia_at_a_general_hospital:_prognosis_factors_and_impact_of_early_empiric_treatment_on_outcome__2002_2005__">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19913258/full_citation/Nosocomial_candidemia_at_a_general_hospital:_prognosis_factors_and_impact_of_early_empiric_treatment_on_outcome__2002_2005__">Full Citation</a></description></item><item><title>A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19906090/full_citation/A_rescue_therapy_with_a_combination_of_caspofungin_and_liposomal_amphotericin_B_or_voriconazole_in_children_with_haematological_malignancy_and_refractory_invasive_fungal_infections_</link><description>Yilmaz D, Balkan C, Ay Y, et al. <br/><span class="title">A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections. [JOURNAL ARTICLE]</span><br/><span class="source" title="Mycoses">Mycoses 2009 Nov 10.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19906090/abstract/A_rescue_therapy_with_a_combination_of_caspofungin_and_liposomal_amphotericin_B_or_voriconazole_in_children_with_haematological_malignancy_and_refractory_invasive_fungal_infections_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19906090/full_citation/A_rescue_therapy_with_a_combination_of_caspofungin_and_liposomal_amphotericin_B_or_voriconazole_in_children_with_haematological_malignancy_and_refractory_invasive_fungal_infections_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19906090/A_rescue_therapy_with_a_combination_of_caspofungin_and_liposomal_amphotericin_B_or_voriconazole_in_children_with_haematological_malignancy_and_refractory_invasive_fungal_infections_">Find Related Articles</a> </description></item><item><title>Kodamaea ohmeri fungaemia successfully treated with caspofungin.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19896340/full_citation/Kodamaea_ohmeri_fungaemia_successfully_treated_with_caspofungin_</link><description>Chiu CH, Wang YC, Shang ST, et al. <br/><span class="title">Kodamaea ohmeri fungaemia successfully treated with caspofungin. [LETTER]</span><br/><span class="source" title="International journal of antimicrobial agents">Int J Antimicrob Agents 2009 Nov 4.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19896340/full_citation/Kodamaea_ohmeri_fungaemia_successfully_treated_with_caspofungin_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19896340/Kodamaea_ohmeri_fungaemia_successfully_treated_with_caspofungin_">Find Related Articles</a> </description></item><item><title>Exposure to caspofungin activates Cap and Hog pathways in Candida albicans.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19888802/full_citation/Exposure_to_caspofungin_activates_Cap_and_Hog_pathways_in_Candida_albicans_</link><description>Kelly J, Rowan R, McCann M, et al. <br/><span class="title">Exposure to caspofungin activates Cap and Hog pathways in Candida albicans. [Journal Article]</span><br/><span class="source" title="Medical mycology : official publication of the International Society for Human and Animal Mycology">Med Mycol 2009 Nov; 47(7):697-706.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19888802/abstract/Exposure_to_caspofungin_activates_Cap_and_Hog_pathways_in_Candida_albicans_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19888802/full_citation/Exposure_to_caspofungin_activates_Cap_and_Hog_pathways_in_Candida_albicans_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19888802/Exposure_to_caspofungin_activates_Cap_and_Hog_pathways_in_Candida_albicans_">Find Related Articles</a> </description></item><item><title>Vertebral osteomyelitis due to Aspergillus fumigatus in a patient with chronic granulomatous disease successfully treated with antifungal agents and interferon-gamma.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19886765/full_citation/Vertebral_osteomyelitis_due_to_Aspergillus_fumigatus_in_a_patient_with_chronic_granulomatous_disease_successfully_treated_with_antifungal_agents_and_interferon_gamma_</link><description>Al-Tawfiq JA, Al-Abdely HM <br/><span class="title">Vertebral osteomyelitis due to Aspergillus fumigatus in a patient with chronic granulomatous disease successfully treated with antifungal agents and interferon-gamma. [JOURNAL ARTICLE]</span><br/><span class="source" title="Medical mycology : official publication of the International Society for Human and Animal Mycology">Med Mycol 2009 Nov 3.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19886765/abstract/Vertebral_osteomyelitis_due_to_Aspergillus_fumigatus_in_a_patient_with_chronic_granulomatous_disease_successfully_treated_with_antifungal_agents_and_interferon_gamma_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19886765/full_citation/Vertebral_osteomyelitis_due_to_Aspergillus_fumigatus_in_a_patient_with_chronic_granulomatous_disease_successfully_treated_with_antifungal_agents_and_interferon_gamma_">Full Citation</a></description></item><item><title>Susceptibility testing of Candida species to echinocandins: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion and agar-dilution using RPMI and IsoSensitest medium.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19884370/full_citation/Susceptibility_testing_of_Candida_species_to_echinocandins:_comparison_of_EUCAST_EDef_7_1_CLSI_M27_A3_Etest_disk_diffusion_and_agar_dilution_using_RPMI_and_IsoSensitest_medium_</link><description>Arendrup MC, Garcia-Effron G, Lass-Flörl C, et al. <br/><span class="title">Susceptibility testing of Candida species to echinocandins: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion and agar-dilution using RPMI and IsoSensitest medium. [JOURNAL ARTICLE]</span><br/><span class="source" title="Antimicrobial agents and chemotherapy">Antimicrob Agents Chemother 2009 Nov 2.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19884370/abstract/Susceptibility_testing_of_Candida_species_to_echinocandins:_comparison_of_EUCAST_EDef_7_1_CLSI_M27_A3_Etest_disk_diffusion_and_agar_dilution_using_RPMI_and_IsoSensitest_medium_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19884370/full_citation/Susceptibility_testing_of_Candida_species_to_echinocandins:_comparison_of_EUCAST_EDef_7_1_CLSI_M27_A3_Etest_disk_diffusion_and_agar_dilution_using_RPMI_and_IsoSensitest_medium_">Full Citation</a> | <a href="http://aac.asm.org/cgi/pmidlookup%3fview=long%26amp;pmid=19884370">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19884370/Susceptibility_testing_of_Candida_species_to_echinocandins:_comparison_of_EUCAST_EDef_7_1_CLSI_M27_A3_Etest_disk_diffusion_and_agar_dilution_using_RPMI_and_IsoSensitest_medium_">Find Related Articles</a> </description></item><item><title>High incidence of Candida parapsilosis candidaemia in non-neutropenic critically ill patients: Epidemiology and antifungal susceptibility.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19883150/full_citation/High_incidence_of_Candida_parapsilosis_candidaemia_in_non_neutropenic_critically_ill_patients:_Epidemiology_and_antifungal_susceptibility_</link><description>Dizbay M, Fidan I, Kalkanci A, et al. <br/><span class="title">High incidence of Candida parapsilosis candidaemia in non-neutropenic critically ill patients: Epidemiology and antifungal susceptibility. [JOURNAL ARTICLE]</span><br/><span class="source" title="Scandinavian journal of infectious diseases">Scand J Infect Dis 2009 Nov 2.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19883150/abstract/High_incidence_of_Candida_parapsilosis_candidaemia_in_non_neutropenic_critically_ill_patients:_Epidemiology_and_antifungal_susceptibility_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19883150/full_citation/High_incidence_of_Candida_parapsilosis_candidaemia_in_non_neutropenic_critically_ill_patients:_Epidemiology_and_antifungal_susceptibility_">Full Citation</a></description></item><item><title>Continuous infusion of amphotericin B deoxycholate: an innovative, low-cost strategy in antifungal treatment.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19878457/full_citation/Continuous_infusion_of_amphotericin_B_deoxycholate:_an_innovative_low_cost_strategy_in_antifungal_treatment_</link><description>Falci DR, Dos Santos RP, Wirth F, et al. <br/><span class="title">Continuous infusion of amphotericin B deoxycholate: an innovative, low-cost strategy in antifungal treatment. [JOURNAL ARTICLE]</span><br/><span class="source" title="Mycoses">Mycoses 2009 Oct 28.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19878457/abstract/Continuous_infusion_of_amphotericin_B_deoxycholate:_an_innovative_low_cost_strategy_in_antifungal_treatment_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19878457/full_citation/Continuous_infusion_of_amphotericin_B_deoxycholate:_an_innovative_low_cost_strategy_in_antifungal_treatment_">Full Citation</a></description></item><item><title>invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19850903/full_citation/invasive_aspergillosis_in_patients_with_acute_myeloid_leukemia:_SEIFEM_2008_registry_study_</link><description>Pagano L, Caira M, Candoni A, et al. <br/><span class="title">invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. [JOURNAL ARTICLE]</span><br/><span class="source" title="Haematologica">Haematologica 2009 Oct 22.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19850903/abstract/invasive_aspergillosis_in_patients_with_acute_myeloid_leukemia:_SEIFEM_2008_registry_study_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19850903/full_citation/invasive_aspergillosis_in_patients_with_acute_myeloid_leukemia:_SEIFEM_2008_registry_study_">Full Citation</a></description></item></channel></rss>